LDLR and glioblastoma: The 4F-KLA-LDL peptide was synthesized by combining the pro-apoptotic peptide KLA with an LDL-targeting peptide, which selectively binds to the overexpressed LDL receptors on blood-brain barrier (BBB) and glioblastoma (GBM) cell lines.